BriaCell Therapeutics's total assets for Q3 2026 were C$27.07M, a decrease of -19.42% from the previous quarter. BCTX total liabilities were C$3.66M for the fiscal quarter, a 9.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.